Visit COVID-19 resources

[Skip to Content]

The incidence and risk factors for the development of vitreomacular interface abnormality in diabetic macular edema treated with intravitreal injection of anti-VEGF – (Eye 31, 762 (May 2017))

11 May 2017

This news item is available to RCOphth members only, please log in below to access.

Members Login